Milestones in hematology

CME Webinar

Milestones in hematology

2 Nov 2023
16:00 - 18:00
online
SGAIM | F-005240 | 2 Credits
Registration for this event is no longer possible

The webinar is product-neutral and free of charge. During the training, participants have the opportunity to ask the speaker questions via chat.

Program

16:00
Welcome
16:00
17:00
10 years’ experience with ruxolitinib First approved in MF, followed by PV and GvHD
(Professor Dr. med. Sara Christina Meyer)
17:00
17:55
10 years’ experience with ibrutinib in MCL: Optimizing treatment now and in future
(Professor Dr. med. Martin Dreyling)
17:55
18:00
Farewell
We are able to realize this webinar thanks to the kind support of Novartis and Janssen.
Novartis Logo
Sponsoren-Logo Janssen